ArriVent BioPharma Insider Trades

AVBP

Track insider trading activity from ArriVent BioPharma executives and directors. See which insiders are buying and selling AVBP stock.

Trades Last 12 Months

AVBP Price

All Insider Trades for ArriVent BioPharma

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Parsey Merdad Director
Holding Value $441k 13,562 shares
Last Trade
Jun 18, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$430k 13,562 shares
$31.74
$32.54
Holding Value $441k 13,562 shares
Last Trade
Jun 18, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$430k 13,562 shares
$31.74
$32.54
Hohneker John Director
Holding Value $441k 13,562 shares
Last Trade
Jun 18, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$430k 13,562 shares
$31.74
$32.54
Nolet Chris Director
Holding Value $441k 13,562 shares
Last Trade
Jun 18, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$430k 13,562 shares
$31.74
$32.54
Lutzker Stuart President Of R&d
Holding Value $4.88M 150,000 shares
Last Trade
Feb 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.4M 150,000 shares
$22.67
$32.54
Yao Zhengbin President And CEO
Holding Value $17.9M 550,000 shares
Last Trade
Feb 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$12.5M 550,000 shares
$22.67
$32.54
Kastenmayer James Paul General Counsel
Holding Value $4.23M 130,000 shares
Last Trade
Feb 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.95M 130,000 shares
$22.67
$32.54
Kung Winston Chief Financial Officer
Holding Value $4.56M 140,000 shares
Last Trade
Feb 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.17M 140,000 shares
$22.67
$32.54
La Chapelle Robin Chief Operating Officer
Holding Value $4.23M 130,000 shares
Last Trade
Feb 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.95M 130,000 shares
$22.67
$32.54
Holding Value $128M 3,929,117 shares
Last Trade
Dec 10, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$13M 555,555 shares
$23.37
$32.54
Lachapelle Robin Chief Operating Officer
Holding Value $419k 12,873 shares
Last Trade
Jul 11, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$241k 11,153 shares
$21.63
$32.54
Holding Value $26.7M 821,827 shares
Last Trade
Jan 30, 2024 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$18.1M 821,827 shares
$22.00
$32.54
Healy James Director
Holding Value $0 0 shares
Last Trade
Jan 30, 2024 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$27.6M 1,252,308 shares
$22.00
$32.54

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up